Does the Invitation by the General Practitioner Improve Patients' Participation in Colorectal Cancer Screening?

Not Applicable

• Conditions: Colorectal Cancer
• Interventions: Other: Classical Letter; Other: Co-signed letter

• Registration Number: NCT01279278
• Lead Sponsor: University of Paris 5 - Rene Descartes

Brief Summary

The propose of this study is to assess the effect of general practitioner's involvement on first patients' solicitation in screening for colorectal cancer by testing for faecal occult blood (FOBT).

Detailed Description

Not available

Study Timeline

• Status Verified: 2010-09
• Study Start: 2010-09
• Study First Submitted: 2011-01-18
• Study First Submitted QC: 2011-01-18
• Last Update Submitted: 2011-01-18
• Study First Posted: 2011-01-19
• Last Update Posted: 2011-01-19
• Primary Completion: 2011-04
• Study Completion: 2011-04

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 2700

Inclusion Criteria

• Aged : 50 to 74 years.
• Not having ever been invited to participate in colorectal screening.

Exclusion Criteria

• Patients who have a Fecal Occult Blood Test for less than 2 years or a colonoscopy within the past 5 years or excluded for medical reasons (according to information known from ADECA).

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Control	Classical Letter	-
Co-signed Letter	Co-signed letter	-

Primary Outcome Measures

Name	Time	Method
Completion of Fecal Occult Blod Test	7 months	Increased number of patients who completed the test for faecal occult blood following the first solicitation with the letter co-signed by general practitioner, compared with the conventional solicition(including replies exclusions).

Secondary Outcome Measures

Name	Time	Method
Measure the impact of co-signing on deadline for completion of the test after the mailing.	7 months
Compare the proportion of uninterpretable tests.	7 months
Compare the rate of completion of colonoscopy after a positive test (information received by ADECA in the follow-up), according to the specifications.	7 months

Trial Locations

Locations (1)

Université Paris Descartes; 🇫🇷 Paris, Ile de France, France